Cystnil Tablet

Polycystic ovary syndrome (PCOS), anovulation, menstrual disorders such as irregular menstruation, amenorrhea, hyperandrogenism complaints such as hirsutism, acne, acanthosis nigricans, insulin resistance, metabolic syndrome, diabetes, ovarian hyperstimulation syndrome, miscarriage

Oral Tablet 1 tab 2 times daily for at least 3 months Can be taken with or without foods

Patients with a known hypersensitivity to any component of this product.

Patients with diabetes should be cautious about the use of this medication. Limited data is available regarding the usage in patients with liver & hepatic impairment.

Several human studies have been conducted in pregnant women with D-chiro-inositol and Myo-inositol combination that show no clinically relevant adverse effects. There are no published clinical data on the safety of D-chiro-inositol and Myo-inositol during lactation.

Inositol may lower blood sugar levels. Taking inositol along with diabetes medications might reduce blood sugar level. Concurrent use with digoxin may result in increased digoxin toxicity.

Generally well tolerated in the recommended dose. Occasionally may occur nausea, diarrhea and flatulence.

D-chiro-inositol and Myo-inositol are two types of inositol that are naturally occurring in the body. A combination of D-chiro-inositol and Myo-inositol shows beneficial effects for women with Polycystic Ovary Syndrome (PCOS). Combination improves insulin resistance, reduces androgen levels, helps to maintain healthy ovarian functions and promotes ovulation in women with PCOS. It also reduces hyperandrogenism-related skin disorders like hirsutism, acne and acanthosis nigricans.

Cystnil 150 mg+550 mg Tablet manufactured by Acme Laboratories Ltd.. Its generic name is D-chiro-inositol + Myo-inositol.